ArticlebioRxiv : the preprint server for biology2024
Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors.
Arba Karcini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.